Next Article in Journal
Update on Systemic Therapies for Metastatic/Unresectable Pheochromocytomas and Paragangliomas and Future Directions
Previous Article in Journal
Correction: Do et al. Colon Cancer Rates Among Asian Americans: A 2017–2021 Epidemiological Analysis. Cancers 2024, 16, 4254
Previous Article in Special Issue
Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 17
Issue 22
10.3390/cancers17223701
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cancers 2019, 11(3), 340.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Margaryan et al. The Stem Cell Phenotype of Aggressive Breast Cancer Cells. Cancers 2019, 11, 340

by
Naira V. Margaryan
1,2,†,
Hannah Hazard-Jenkins
2,3,†,
Mohamad A. Salkeni
2,4,†,
Matthew B. Smolkin
2,5,
James A. Coad
2,5,
Sijin Wen
2,6,
Elisabeth A. Seftor
1,2,
Richard E. B. Seftor
1,2 and
Mary J. C. Hendrix
7,*
1
Department of Biochemistry, West Virginia University, Morgantown, WV 26506, USA
2
West Virginia University Cancer Institute, West Virginia University, Morgantown, WV 26506, USA
3
Department of Surgery, West Virginia University, Morgantown, WV 26506, USA
4
Department of Internal Medicine, West Virginia University, Morgantown, WV 26506, USA
5
Department of Pathology, Anatomy and Laboratory Medicine, West Virginia University School of Medicine, Morgantown, WV 26506, USA
6
Department of Biostatistics, School of Public Health, West Virginia University, Morgantown, WV 26506, USA
7
Department of Biology, Shepherd University, Shepherdstown, WV 25443, USA
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2025, 17(22), 3701; https://doi.org/10.3390/cancers17223701
Submission received: 4 November 2025 / Accepted: 6 November 2025 / Published: 19 November 2025
(This article belongs to the Special Issue Advances in Cancer Stem Cell Research)
Browse Figure
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in Figure 4 as published. Figure 4 was found to have incorrectly duplicated the post-treatment IgG (control) image in place of the SH-11 pre-TCHP image. All original images for this paper were reviewed and the correct SH-11 pre-TCHP image representing the SH-11 pre-TCHP sample has been inserted in Figure 4. The corrected Figure 4 appears below. The authors confirm that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Margaryan, N.V.; Hazard-Jenkins, H.; Salkeni, M.A.; Smolkin, M.B.; Coad, J.A.; Wen, S.; Seftor, E.A.; Seftor, R.E.B.; Hendrix, M.J.C. The Stem Cell Phenotype of Aggressive Breast Cancer Cells. Cancers 2019, 11, 340. [Google Scholar] [CrossRef] [PubMed]
Cancers 17 03701 g004
Figure 4. The presence of the ABCA1 protein (brown color) in breast cancer patient tumor sections, pre- and post-current-standard-of-care-treatments (ACT, TCHP, and TC) was examined by immunohistochemical staining with IgG used as a control for non-specific staining (20× original magnification).
Figure 4. The presence of the ABCA1 protein (brown color) in breast cancer patient tumor sections, pre- and post-current-standard-of-care-treatments (ACT, TCHP, and TC) was examined by immunohistochemical staining with IgG used as a control for non-specific staining (20× original magnification).
Cancers 17 03701 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Margaryan, N.V.; Hazard-Jenkins, H.; Salkeni, M.A.; Smolkin, M.B.; Coad, J.A.; Wen, S.; Seftor, E.A.; Seftor, R.E.B.; Hendrix, M.J.C. Correction: Margaryan et al. The Stem Cell Phenotype of Aggressive Breast Cancer Cells. Cancers 2019, 11, 340. Cancers 2025, 17, 3701. https://doi.org/10.3390/cancers17223701

AMA Style

Margaryan NV, Hazard-Jenkins H, Salkeni MA, Smolkin MB, Coad JA, Wen S, Seftor EA, Seftor REB, Hendrix MJC. Correction: Margaryan et al. The Stem Cell Phenotype of Aggressive Breast Cancer Cells. Cancers 2019, 11, 340. Cancers. 2025; 17(22):3701. https://doi.org/10.3390/cancers17223701

Chicago/Turabian Style

Margaryan, Naira V., Hannah Hazard-Jenkins, Mohamad A. Salkeni, Matthew B. Smolkin, James A. Coad, Sijin Wen, Elisabeth A. Seftor, Richard E. B. Seftor, and Mary J. C. Hendrix. 2025. "Correction: Margaryan et al. The Stem Cell Phenotype of Aggressive Breast Cancer Cells. Cancers 2019, 11, 340" Cancers 17, no. 22: 3701. https://doi.org/10.3390/cancers17223701

APA Style

Margaryan, N. V., Hazard-Jenkins, H., Salkeni, M. A., Smolkin, M. B., Coad, J. A., Wen, S., Seftor, E. A., Seftor, R. E. B., & Hendrix, M. J. C. (2025). Correction: Margaryan et al. The Stem Cell Phenotype of Aggressive Breast Cancer Cells. Cancers 2019, 11, 340. Cancers, 17(22), 3701. https://doi.org/10.3390/cancers17223701

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop